Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Stella Pharma's share price for the quarter that ended in Mar. 2026 was 円759. Stella Pharma's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 34.0 Mil. Therefore, Stella Pharma's market cap for the quarter that ended in Mar. 2026 was 円25,821.2 Mil.
Stella Pharma's quarterly market cap
declined
from Sep. 2025 (円12,181.0 Mil) to Dec. 2025 (円6,907.1 Mil) but then
increased
from Dec. 2025 (円6,907.1 Mil) to Mar. 2026 (円25,821.2 Mil).
Stella Pharma's annual market cap
increased
from Mar. 2024 (円9,024.0 Mil) to Mar. 2025 (円13,033.1 Mil) and
increased
from Mar. 2025 (円13,033.1 Mil) to Mar. 2026 (円25,821.2 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Stella Pharma's Enterprise Value for Today is 円10,890.6 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Stella Pharma Market Cap Related Terms
Stella Pharma Market Cap Historical Data
* Premium members only.
The historical data trend for Stella Pharma's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4888 vs VRTX, REGN, RVMD: Market Cap Comparison
For the Biotechnology subindustry, Stella Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stella Pharma Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Stella Pharma's Market Cap distribution charts can be found below:
* The bar in red indicates where Stella Pharma's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Stella Pharma's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stella Pharma (TSE:4888) has a Market Cap of 円12,966.5 Mil as of Aug. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Stella Pharma and its competitors. According to the industry distribution chart, Stella Pharma ranks #808 out of 1421 companies in the Biotechnology industry, placing it in the top 56.9%.
Is Stella Pharma's Market Cap too high?
Stella Pharma's current Market Cap is 円12,966.5 Mil. Based on the distribution chart, Stella Pharma ranks #808 out of 1421 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Stella Pharma has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Stella Pharma's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Stella Pharma ranks #808 out of 1421 companies for Market Cap. This places Stella Pharma in the lower half of its industry. The industry median Market Cap is 122.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 122.85, based on 1,421 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Stella Pharma and its competitors. For the Biotechnology industry, the median Market Cap is 122.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stella Pharma's current Market Cap is 円12,966.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stella Pharma stock overvalued right now?
Based on GuruFocus' analysis, Stella Pharma (TSE:4888) is currently considered Fairly Valued. The stock's GF Value™ is 円370.57, compared to a current price of 円360.00 — trading 2.9% below its estimated fair value. The current Market Cap is 円12,966.5 Mil. Stella Pharma's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Stella Pharma (TSE:4888), the current Market Cap is 円12,966.5 Mil as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Stella Pharma (TSE:4888) Overvalued in 2026?
Based on GuruFocus' analysis, Stella Pharma stock appears to be undervalued.
The current stock price of 円360.00 is trading 2.9% below its estimated GF Value™ of 円370.57.
GuruFocus considers Stella Pharma to be Fairly Valued.
Key valuation signals for TSE:4888:
Market Cap: 円12,966.5 Mil
GF Value™: 円370.57 vs. price of 円360.00 (2.9% below fair value)
No single metric tells the full story. See the TSE:4888 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.
77GF Score
Get the complete analysis for TSE:4888
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4888 has been successfully added to your 
